Public disclosure of inside information according to article 17 MAR

TELES AG: Changes to the Supervisory Board

Berlin (pta039/28.05.2024/12:00 UTC+2)

Mr. Joachim Schwarzer, Chairman of the Supervisory Board of TELES AG, has declared to the Supervisory Board of Teles AG that he will resign from office for personal reasons with effect from the end of the next Annual General Meeting.

The Management Board and Supervisory Board deeply regret Mr. Schwarzer's decision. The company thanks Mr. Schwarzer for his many years of successful work.

A proposal for the election of a Supervisory Board member to succeed the departing member will be submitted for resolution at the company's next Annual General Meeting.

About TELES AG (ISIN DE000A289B07 / WKN A289B0):

TELES is a specialized pharmaceutical supplier that ensures optimal pharmaceutical care for patients with a digitalized supply chain. Medicines for cancer, autoimmune deficiencies and combination therapies for personalized medicine are delivered quickly and reliably throughout Europe.

The need for indication-specific drugs is increasing across Europe and TELES is benefiting from this growth. The European pharmaceutical market is a stable growth market and TELES supplies predominantly German medicines with a high export share. TELES is one of the largest specialty pharmacy companies in Germany.


Emitter: TELES AG
Ordensmeisterstraße 15-16
12099 Berlin
Contact Person: Sascha Knoche
Phone: +49 170 8257343
ISIN(s): DE000A289B07 (Share)
Stock Exchange(s): Regulated Market in Frankfurt, Tradegate (Regulated Market); Free Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart